Synergene

What Synergene does

Synergene Active Ingredients Private Limited, founded in 2006 and headquartered in Hyderabad, India, is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals for personal care applications. The company serves 300+ customers across 50+ countries, supplying global generic pharmaceutical manufacturers including Dr. Reddy's Laboratories, Sanofi, Cipla, Lupin, Viatris, Daiichi Sankyo, and Hetero. Its commercial portfolio spans 30+ APIs across antifungal, antidepressant, antimigraine, antihypertensive, antihistamine, anti-diabetic, anticoagulant, and other therapeutic categories, supported by an oncology intermediates portfolio and a specialty chemicals range covering UV filters, skincare actives, and haircare ingredients.

The company operates five manufacturing facilities — Unit I and Central R&D in Bachupally, Hyderabad (established 2006), and four facilities at Parawada, Visakhapatnam: Unit II (160 KL, 2010), Jaahnavee Life Sciences (170 KL, acquired 2018), Unit III (380 KL, 2019), and Synac Pharmaceuticals (90 KL, established 2023 with an additional 700 KL under installation). Aggregate reactor capacity exceeds 800 KL. Core process chemistry capabilities include Grignard reactions, asymmetric reduction, high-pressure hydrogenation, N-Butyl Lithium, chiral synthesis, and complex multi-step synthesis, supported by analytical R&D infrastructure (LCMS, GCMS, UPLC). The company holds four granted process patents covering synthesis routes for Escitalopram Oxalate, S(+) Dapoxetine Hydrochloride, Luliconazole, and Terbinafine Hydrochloride.

Synergene generates revenue through direct B2B sales of APIs, intermediates, and specialty chemicals to pharmaceutical manufacturers, with quote-based pricing tied to volume and regulatory documentation requirements. Revenue is supplemented by licensing and filing fees from DMF registrations in 50+ countries, including USDMFs, CEPs (EDQM), JDMFs, IDLs (NMPA), and TPD Health Canada Master Files. The regulatory footprint is anchored by USFDA, EDQM, PMDA, ANVISA, WHO-GMP, and ISO 9001/14001/45001 certifications. The company is privately held and founder-controlled under Chairman and Managing Director Surya Prakash Rao Nalla, who reports annual turnover of $50 million USD.

Name

Synergene

Legal name

Synergene Active Ingredients Pvt Ltd

Website

https://synergeneapi.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Synergene Active Ingredients is an India-based manufacturer of Active Pharmaceutical Ingredients, pharmaceutical intermediates, and personal care specialty chemicals. Founded in 2006 and headquartered in Hyderabad, the company operates five manufacturing facilities and serves 300+ pharmaceutical customers across 50+ countries.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (API) Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE), Custom Intermediates & Advanced Intermediates Manufacturing (HLAGAHAH), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical intermediates
• API manufacturing
• Specialty chemicals
• Generic drug manufacturing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (APIs): Manufacturing and sale of Active Pharmaceutical Ingredients including Terbinafine Hydrochloride, Fluconazole, Voriconazole, Escitalopram Oxalate, Losartan Potassium, and 25+ other APIs to pharmaceutical companies globally
2. Pharmaceutical Intermediates: Supply of pharmaceutical intermediates for various therapeutic categories including oncology, CNS, and cardiovascular drugs
3. Specialty Chemicals: Personal care ingredients including UV filters (Avobenzone, EHT, PBSA, DHBT, Bemotrizinol), skincare actives (4-n-butylresorcinol, Salicylic Acid, Hexylresorcinol), and haircare ingredients (Piroctone Olamine, Minoxidil, Climbazole)
4. Regulatory Filing Services: DMF filings in multiple countries for various APIs, generating licensing and filing fee revenue

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

Synergene is a B2B manufacturer and global supplier of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals for the personal care industry. The company produces 30+ commercial APIs across therapeutic categories such as antifungals, antidepressants, antihypertensives, antihistamines, and oncology intermediates, and supports customers with multi-jurisdictional regulatory filings including USDMF, CEP, and DMFs in 50+ countries.

Product overview

Synergene Active Ingredients Private Limited is a pharmaceutical manufacturer offering a portfolio of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and personal care specialty chemicals. The core offering consists of 30+ commercial APIs across therapeutic segments including antifungals (Terbinafine Hydrochloride, Fluconazole, Voriconazole, Luliconazole), antidepressants (Escitalopram Oxalate, Citalopram Hydrobromide, Vortioxetine), antimigraines (Sumatriptan), antihypertensives (Losartan Potassium, Olmesartan Medoxomil, Irbesartan), antihistamines (Bilastine, Fexofenadine Hydrochloride), and other therapeutic categories. The company also manufactures pharmaceutical intermediates including oncology intermediates, and specialty chemicals for sun care, skincare, and haircare applications. Synergene operates multiple manufacturing facilities in India and provides regulatory filing services (CEP, USDMF, JDMF, DMFs) to support global pharmaceutical clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Commercial Active Pharmaceutical Ingredients manufactured under cGMP standards for global generic and therapeutic pharmaceutical manufacturers across multiple therapeutic categories, with multi-jurisdictional regulatory filings.
• Pharmaceutical Intermediates Pharmaceutical intermediates supplied to API manufacturers and drug developers across therapeutic categories including oncology, cardiovascular, CNS, anti-inflammatory, anti-diabetic, and anti-infective applications.
• Specialty Chemicals (Sun Care, Skincare, Haircare) Specialty chemicals for cosmetics and personal care manufacturers, including UV filters for sunscreen formulations, skin-brightening and acne-treatment actives for skincare, and anti-dandruff and hair-regrowth compounds for haircare products.
• Pipeline APIs (Products Under Development) APIs currently in development and validation stages, intended for future commercial supply to pharmaceutical manufacturers across diverse therapeutic categories.
• Regulatory Filing Services Multi-jurisdictional regulatory filing services — including CEP from EDQM, IDL from NMPA, USDMF, JDMF, TPD Health Canada Master File, and country-specific DMFs in 50+ countries — supporting customer submissions for finished pharmaceutical products.

Quantifiable outcome

• Annual turnover of 50 million USD
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Divi's Laboratories: Divi's is one of India's largest API manufacturers with deep capabilities in chiral synthesis and complex chemistry, supplying global generic pharmaceutical companies. Directly comparable on technology and target customers, but operates at meaningfully larger scale and a broader therapeutic footprint.
• Aurobindo Pharma: Aurobindo is one of India's largest vertically integrated pharmaceutical companies with significant captive API manufacturing across multiple therapeutic categories including antifungals and cardiovasculars. Comparable on API portfolio and regulatory certifications, but operates at vastly larger scale and includes finished dosage forms.
• Piramal Pharma Solutions: Piramal operates a CDMO/API business with strong process chemistry, USFDA-inspected facilities, and supply relationships with global pharma customers. Comparable on regulatory depth and B2B API supply, though service offerings and contract development emphasis differ.

Direct peers

• Laurus Labs: Laurus Labs is an Indian API and intermediates manufacturer with strong process chemistry capabilities, USFDA/EDQM filings, and B2B relationships with global generic pharma companies. Highly comparable in therapeutic breadth, regulatory footprint, and customer base, though somewhat larger.
• Neuland Laboratories: Neuland is an Indian API and intermediate manufacturer focused on complex small molecules, chiral synthesis, and contract development, supplying global generic and innovator pharma customers. Closely comparable in scale, technology positioning, and regulatory-driven B2B go-to-market.
• MSN Laboratories: MSN Labs is an Indian generic API manufacturer with USFDA-inspected facilities, CEP certifications, and a product portfolio spanning CNS, cardiovascular, and antifungal APIs. Highly comparable in molecules, regulatory certifications, and target customers.
• Sai Life Sciences: Sai Life Sciences is an Indian contract research and API manufacturer with capabilities in complex chemistry, chiral synthesis, and regulatory documentation for global pharma customers. Closely comparable in process chemistry capabilities and customer base, with stronger CDMO orientation.

Emerging players

• Granules India: Granules is an Indian pharmaceutical company with significant API manufacturing operations across therapeutic categories, supplying global generic companies. Comparable in target customer and API portfolio, with stronger emphasis on finished dosage forms.
• Shilpa Medicare: Shilpa Medicare is an Indian API and intermediates manufacturer with USFDA-inspected facilities and regulatory filings across major markets. Comparable in API manufacturing and regulatory positioning, though Shilpa has expanded more aggressively into biologics and CDMO.

Regional players

• Metrochem API Pvt Ltd: Metrochem is an Indian API manufacturer co-founded by Synergene's Chairman in 1997, focused on small-molecule APIs for global generic markets. Comparable in size, technology, and customer base, with direct founder linkage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/synergeneapi
• LinkedInlinkedin.com/company/synergeneapi

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergene